Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Feb 7, 2006; 12(5): 739-746
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.739
Published online Feb 7, 2006. doi: 10.3748/wjg.v12.i5.739
Crohn's disease activity parameters | ||||||
CDAI | CRP | ESR | Platelets | SerumTNF-α | ||
Urine m-ALB | rS | 0.1186 | 0.0326 | 0.0352 | 0.1483 | 0.1537 |
(μg/min) | P | 0.2856 | 0.7686 | 0.7522 | 0.1810 | 0.1654 |
Urine β2mGLB | rS | 0.0813 | 0.0187 | 0.0624 | 0.1727 | 0.2100 |
(μg/min) | P | 0.4648 | 0.8669 | 0.5751 | 0.1184 | 0.0568 |
Urine β-NAG | rS | 0.1106 | 0.0319 | 0.0947 | 0.0527 | 0.2676 |
(U/L) | P | 0.3196 | 0.7744 | 0.3347 | 0.6359 | 0.0145 |
- Citation: Poulou AC, Goumas KE, Dandakis DC, Tyrmpas I, Panagiotaki M, Georgouli A, Soutos DC, Archimandritis A. Microproteinuria in patients with inflammatory bowel disease: Is it associated with the disease activity or the treatment with 5-aminosalicylic acid? World J Gastroenterol 2006; 12(5): 739-746
- URL: https://www.wjgnet.com/1007-9327/full/v12/i5/739.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i5.739